a
RTI Biologics, an Alachua, Fla.-based orthopedic device company, has launched the BioAdapt DBM Foam, a flexible demineralized bone matrix solution, according to a company news release.
BioAdapt offers five pre-shaped options to match the bone grafting needs of trauma, reconstructive, spine and extremities cases. The solution is designed to expand with hydration and can adapt to the contours of the surgical site.
Read the release about BioAdapt.
Related Articles on RTI Biologics:
RTI Biologics Develops Reimbursement Hotline for Sports Medicine
RTI Pays $3M for Athersys Orthopedic Implant Technology
RTI Biologics Reports 4Q Revenue at $45.4M, 8% Increase
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.